28 related articles for article (PubMed ID: 10781850)
21. Influence of live respiratory syncytial virus priming on the immune response generated by a recombinant vaccine candidate, BBG2Na.
Goestch L; Plotnicky-Gilquin H; Champion T; Beck A; Haeuw JF; Nguyen T; Bonnefoy JY; Corvaïa N
Vaccine; 2000 Jun; 18(24):2648-55. PubMed ID: 10781850
[TBL] [Abstract][Full Text] [Related]
22. Respiratory syncytial virus infection in older persons.
Falsey AR
Vaccine; 1998 Nov; 16(18):1775-8. PubMed ID: 9778756
[TBL] [Abstract][Full Text] [Related]
23. Nanoparticle vaccines against respiratory viruses.
Adair BM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):405-14. PubMed ID: 20049806
[TBL] [Abstract][Full Text] [Related]
24. Approaches to immunization against respiratory syncytial virus.
Wertz GW; Sullender WM
Biotechnology; 1992; 20():151-76. PubMed ID: 1600380
[No Abstract] [Full Text] [Related]
25. Progress towards recombinant anti-infective antibodies.
Pai JC; Sutherland JN; Maynard JA
Recent Pat Antiinfect Drug Discov; 2009 Jan; 4(1):1-17. PubMed ID: 19149692
[TBL] [Abstract][Full Text] [Related]
26.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
